Valeritas

The official Twitter feed of Valeritas, a type 2 diabetes company and the maker of V-Go®. To learn more, visit

[Valeritas @Valeritas_US]

See V-Go® Important Safety Information here: https://t.co/aL4f8RHyag

[Valeritas @Valeritas_US]

Valeritas, Inc. has now joined Zealand Pharma. Employees, all supporting systems, processes and the majority of established contracts, and a site in Marlborough, MA, are transferred to Zealand Pharma. Connect with us here to continue getting our updates. https://t.co/DED9kw0ZMD

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year’ which can be accessed at the following link: https://t.co/9xzJ3SWrgm $VLRX

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting’ which can be accessed at the following link: https://t.co/DiMF0lCnKe @AmEpilepsySoc #CBD #Epilepsy #AES2019 $VLRX

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage’ which can be accessed at the following link: https://t.co/wEM68hnknC #diabetes #insulin #VLRX

[Valeritas @Valeritas_US]

Valeritas press release: 'Valeritas Announces Third Quarter 2019 Financial Results' which can be accessed at the following link: https://t.co/Dyf79fH4WQ $VLRX

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)’ which can be accessed at the following link: https://t.co/uLVQ2LlX9Z #VLRX #WCN2019 #neurology #Parkinsons

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019’ which can be accessed at the following link: https://t.co/z8G4re8TPV $VLRX

[Valeritas @Valeritas_US]

Valeritas press release: ‘GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclinical Study’ which can be accessed at the following link: https://t.co/iHfk8jj6z6 $VLRX #diabetes #obesity #liver

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia’ which can be accessed at this link: https://t.co/JEFrHbq87C $VLRX #dementia #Dementia2019 #Parkinsons #Alzheimers

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's Annual Meeting’ which can be accessed at the following link: https://t.co/WmiZcpHGqF @AmEpilepsySoc $VLRX #CBD #epilepsy #AES2019

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2019)’ which can be accessed at the following link: https://t.co/pViT0fOL9h @wfneurology #WCN2019 $VLRX #neurology

[Valeritas @Valeritas_US]

Stop by our exhibit booth at #MEDSummit2019 to find out how to optimize delivery of insulin for patients with #T2D. $vlrx

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Hosts Educational Symposium and Participates in the Metabolic & Endocrine Disease Summit (MEDS) East’ which can be accessed at the following link: https://t.co/XrAs4KScKc $VLRX @GlobalAcadCME #diabetes #nursepractitioner #physicianassistant

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Converts $25 Million of Long-Term Debt Obligation to CRG into Series B Convertible Preferred Stock,’ which can be accessed at the following link: https://t.co/B1fUwb8cEt $VLRX

[Valeritas @Valeritas_US]

@DrJessBarnes1 presented a poster on positive h-Patch™ #CBD Study Data @CannMed Conference $VLRX #cannmed2019

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Announces Participation on “The Cutting Edge of Cannabinoid Science” Panel at the CBD Expo EAST Conference’ which can be accessed at the following link: https://t.co/MNblqrWpSt @cbdexpo $VLRX #cbd #cbdexpo

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Presents Positive h-Patch™ CBD Study Data at CannMed Conference’ which can be accessed at the following link: https://t.co/jpXHLB37I7 $VLRX #cbd #cannmed2019

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Announces Presentation of Preclinical h-Patch™ CBD Study at CannMed Conference,’ which can be accessed at the following link: https://t.co/J4fZqKNsvQ $VLRX

[Valeritas @Valeritas_US]

Valeritas press release: ‘Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia’ which can be accessed at the following link: https://t.co/iknHdYe2wM $VLRX

[Valeritas @Valeritas_US]

Dr Jess Barnes presented preclinical PK data on #CBD delivered via Valeritas’ h-Patch™ technology at #ICDP2019. Valeritas CFO Erick Lucera joined Dr. Barnes to entertain follow up questions after the presentation. #cannabinoid #cannabisscience #cannabisindustry #cannabisresearch